share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Bhatt Deepak

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施貴寶 | 4：持股變動聲明
SEC announcement ·  04/03 06:41
牛牛AI助理已提取核心訊息
In a recent transaction, Bhatt Deepak, associated with Bristol-Myers Squibb (BMY), was reported to have engaged in a market action on March 31, 2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the resulting ownership stake, were not disclosed in the announcement. This information is critical for investors to understand the implications of the transaction on their investment decisions.
In a recent transaction, Bhatt Deepak, associated with Bristol-Myers Squibb (BMY), was reported to have engaged in a market action on March 31, 2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the resulting ownership stake, were not disclosed in the announcement. This information is critical for investors to understand the implications of the transaction on their investment decisions.
據報道，在最近的一筆交易中，與百時美施貴寶（BMY）有聯繫的巴特·迪帕克於2024年3月31日參與了市場活動。該交易的具體細節，包括所涉及的股票數量、股票的性質、交易價格以及由此產生的所有權，均未在公告中披露。這些信息對於投資者了解交易對其投資決策的影響至關重要。
據報道，在最近的一筆交易中，與百時美施貴寶（BMY）有聯繫的巴特·迪帕克於2024年3月31日參與了市場活動。該交易的具體細節，包括所涉及的股票數量、股票的性質、交易價格以及由此產生的所有權，均未在公告中披露。這些信息對於投資者了解交易對其投資決策的影響至關重要。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。